DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,806,000 | -10.0% | 112,011 | -3.0% | 0.00% | -25.0% |
| Q2 2021 | $4,227,000 | -21.2% | 115,459 | -3.5% | 0.00% | -20.0% |
| Q1 2021 | $5,365,000 | -0.4% | 119,641 | +26.7% | 0.01% | 0.0% |
| Q4 2020 | $5,388,000 | +26.9% | 94,416 | +14.1% | 0.01% | 0.0% |
| Q3 2020 | $4,245,000 | -19.9% | 82,752 | -6.7% | 0.01% | -16.7% |
| Q2 2020 | $5,297,000 | +55.6% | 88,701 | +7.3% | 0.01% | +20.0% |
| Q1 2020 | $3,405,000 | +1.9% | 82,689 | +54.0% | 0.01% | +66.7% |
| Q4 2019 | $3,343,000 | +526.0% | 53,711 | +237.0% | 0.00% | +200.0% |
| Q3 2019 | $534,000 | +42.8% | 15,940 | -3.9% | 0.00% | – |
| Q2 2019 | $374,000 | – | 16,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
| Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
| BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
| Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
| ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
| Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
| Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
| Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
| Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |